The overall survival for the patients with AML indicates the presence of an inverse relationship between survival and NF-κB expression (e.g., longer survival was associated with patients with low gene expression and vice versa) (Figure 1). The gene discussed is NFKB1; the disease is acute myeloid leukemia.